Asset Management One Co. Ltd. Grows Stock Holdings in HCA Healthcare, Inc. $HCA

Asset Management One Co. Ltd. raised its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 0.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 77,038 shares of the company’s stock after purchasing an additional 477 shares during the period. Asset Management One Co. Ltd.’s holdings in HCA Healthcare were worth $29,513,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of HCA. Chung Wu Investment Group LLC acquired a new position in HCA Healthcare during the second quarter worth approximately $27,000. Ameriflex Group Inc. acquired a new stake in shares of HCA Healthcare in the second quarter worth $27,000. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare in the first quarter valued at $26,000. Saudi Central Bank purchased a new position in shares of HCA Healthcare in the first quarter valued at $26,000. Finally, WPG Advisers LLC bought a new position in HCA Healthcare during the 1st quarter valued at $27,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.5%

HCA Healthcare stock opened at $446.58 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $461.56. The company’s 50-day moving average price is $414.84 and its two-hundred day moving average price is $381.67. The stock has a market cap of $104.50 billion, a price-to-earnings ratio of 18.77, a PEG ratio of 1.39 and a beta of 1.40.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Analyst Ratings Changes

A number of analysts have weighed in on HCA shares. Truist Financial set a $460.00 target price on shares of HCA Healthcare in a report on Tuesday, October 14th. Mizuho increased their target price on shares of HCA Healthcare from $425.00 to $475.00 and gave the stock an “outperform” rating in a report on Friday, October 17th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. UBS Group increased their price objective on shares of HCA Healthcare from $438.00 to $495.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Finally, Wolfe Research cut shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $437.19.

Check Out Our Latest Analysis on HCA Healthcare

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.